Trials / Recruiting
RecruitingNCT05131100
Korean Regulatory Post Marketing Surveillance for Somavert
Korean Post-marketing Surveillance for Somavert
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Non-interventional observational study, to identify safety and effectiveness of Somavert during the post-marketing period based on the Korean RMP as required by the regulations of Ministry of Food and Drug Safety (MFDS)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Somavert | As provided in real world practice |
Timeline
- Start date
- 2022-07-13
- Primary completion
- 2026-09-15
- Completion
- 2026-09-15
- First posted
- 2021-11-23
- Last updated
- 2025-07-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05131100. Inclusion in this directory is not an endorsement.